Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Biotechnologies · China · 2023-08-24

Processing Time
10 days
Decision Date
2023-08-24
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate novel strategies for diagnosis, drug delivery, and immunotherapy to develop new treatments for cancer. His work focuses on developing the AESOP platform, a microfluidic cell deformation system designed to improve the safety and efficiency of intracellular gene editing delivery.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor holds substantial merit and national importance as it addresses cancer treatment and gene editing delivery methods.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of publications, citations, and patent applications indicates he is well-positioned to make further discoveries.

3 On Balance, Beneficial to Waive Job Offer Met

The U.S. would benefit from waiving the job offer requirement due to the petitioner's contributions to national health and welfare.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 4 peer-reviewed journal articles, 2 pre-prints, and 2 patent applications. These works accumulated 55 citations, demonstrating his influence in the field. The case was supported by 4 expert recommendation letters and evidence of funding from major agencies like the NSF and DOE, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Government Alignment

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Massachusetts 313 days 2025-02-03
The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
195 days 2022-05-06
The petitioner proposes to continue developing genomic screening platforms and gene therapy-based approaches to facilitate the design of novel treatment modalities for cancer. This work focuses on identifying genetic factors that contribute to cancer development and progression using state-of-the-art molecular methods.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-08-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 10 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist